Advertisement
Advertisement

XCUR

XCUR logo

Exicure, Inc. Common Stock

3.37
USD
Sponsored
+0.02
+0.60%
May 08, 15:38 UTC -4
Closed
exchange

After-Market

3.37

0.00
0.00%

Exicure, Inc. Common Stock Profile

About

Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.

Info & Links

CEO

Jung Soo Kim

Headquarters

400 Seaport Court, Suite 102
Redwood City, CA 94063, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.exicuretx.com

Auditor

CBIZ CPAs P.C.

Share holders

88

Employees

8

Exicure, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

21.48M

Enterprise Value

17.73M

Enterprise Value/EBITDA(ttm)

-4.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.66

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-138.71%

Return on Invested Capital(ttm)

-111.99%

Return on Assets(ttm)

-62.76%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-3.77M

Net Income Available to Common(ttm)

-4.95M

Diluted EPS(ttm)

-0.77

Share Statistics

Beta (5Y Monthly)

4.02

52-Week Change

-70.39%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.37M

Dividend Yield

0.00%

Float4

3.01M

% Held by Insiders

52.80%

% Held by Institutions

42.82%

Balance Sheet

Total Cash(mrq)

3.75M

Total Cash Per Share(mrq)

0.59

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.19%

Quick Ratio(mrq)

1.19%

Book Value Per Share(mrq)

0.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.36

Free Cash Flow(ytd)

-8.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement